Ultrasound Ablation Offers Option for Some With Prostate Cancer

WEDNESDAY, Sept. 16, 2020 -- For men with localized prostate cancer, hemigland high-intensity focused ultrasound (HIFU) ablation is associated with 73 percent two-year survival free from treatment failure and 91 percent survival free from radical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news

Related Links:

Conclusions: Early evidence suggested the partial-gland HIFU was safer than whole-gland HIFU, and they had similar oncological outcomes. More prospective randomized controlled trials of whole-gland and partial-gland HIFU for PCa was needed.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
We report outcomes of the first prospective cohort of US patients treated with focal HIFU.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Urology Source Type: research
Abstract INTRODUCTION: Some men who experience prostate cancer recurrence post-radiotherapy may be candidates for local salvage therapy, avoiding and delaying systemic treatments. Our aim was to assess the impact of clinical outcomes of adding salvage local treatment in prostate cancer patients who have failed radiation therapy. METHODS: Following radiation biochemical failure, salvage transperineal cryotherapy (sCT, n=186), transrectal high intensity focused ultrasound ablation (sHIFU, n=113) or no salvage treatment (NST, identified from the pan-Canadian Prostate Cancer Risk Stratification [ProCaRS] database...
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Tags: Can Urol Assoc J Source Type: research
Condition:   Prostate Cancer Intervention:   Procedure: high-intensity focused ultrasound, HIFU Sponsor:   The Hospital of Vestfold Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Prostatic Neoplasms Intervention:   Procedure: high-intensity focused ultrasound, HIFU Sponsor:   The Hospital of Vestfold Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(Wolters Kluwer Health) High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in the Journal of Urology ® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Conclusion: PSMA PET/CT has a profound impact on stage and management of PCa patients outside the 2 main classic indications (BCR and presurgical staging) across all examined clinical scenarios.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Clinical Source Type: research
Partial ablation of the prostate using high-intensity focussed ultrasound (HIFU-PA) is a treatment option for localised prostate cancer. When local recurrence occurs, salvage robot-assisted radical prostatecto...
Source: BMC Urology - Category: Urology & Nephrology Authors: Tags: Research article Source Type: research
AbstractBackgroundWe evaluated clinical outcomes of region target focal therapy with high-intensity focused ultrasound (HIFU) for the localized prostate cancer (PCa) based on magnetic resonance imaging-based biopsy and systematic prostate biopsy for Asian.MethodsWe prospectively recruited patients with localized PCa, located their significant tumors using MRI-transrectal ultrasound (TRUS) elastic fusion image-guided transperineal prostate biopsy and 12-cores transperineal systematic biopsy, and focally treated these regions in which the tumors were located in the prostate using HIFU. Patients ’ functional and oncolog...
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
AbstractPurposeFocal therapies (FTs) are investigated within prospective studies on selected patients treated for localized prostate cancer (PCa). Benefits are preservation of genitourinary function and reduced complications, but follow-up is elaborate and is associated with uncertainty as cancer-free survival appears to be lower compared to standard radical treatments. The aim of this study was to analyse patient-reported acceptance of FT and evaluate factors associated with treatment decision regret.Methods52 patients who received focal high-intensity focused ultrasound for low- to intermediate-risk PCa between 2014 and ...
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | High Intensity Focused Ultrasound Therapy | Pharmaceuticals | Prostate Cancer | Ultrasound